Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Eli Lilly

Eli Lilly

ADVERTISEMENT
News and Trends

Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites

Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two…

By Jim Cornall
27/05/2022 - 3 minutes
News and Trends

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

Eli Lilly will partner Oxford-based Sitryx to develop up to four drug candidates to treat…

By Helen Albert
03/04/2020 - 2 minutes
News and Trends

Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M

A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…

By Jonathan Smith
24/03/2020 - 3 minutes
News and Trends

Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close

Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…

By Editorial Team
30/09/2019 - 4 minutes
More News!

AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I

AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…

By Jonathan Smith
23/09/2019 - 2 minutes
News and Trends

Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics

In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1…

By Clara Rodríguez Fernández
06/09/2018 - 2 minutes
News and Trends

Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes

Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…

By Alexander Burik
23/02/2018 - 3 minutes
News and Trends

Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval

Update (13/02/2018): The European Commission has given Novo Nordisk a market authorization for Ozempic (semaglutide), bringing…

By Clara Rodríguez Fernández
13/02/2018 - 2 minutes
News and Trends

Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines

CureVac will be working with pharma giant Eli Lilly in the development of up to…

By Clara Rodríguez Fernández
18/10/2017 - 3 minutes
News and Trends

Eli Lilly Partners with German Biotech Against Autoimmune Disease

Topas Therapeutics has signed a multi-year agreement with Eli Lilly to develop drug candidates for…

By Clara Rodríguez Fernández
22/08/2017 - 2 minutes
More News!

Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s

Novo Nordisk has reported Phase III data that reveal its candidate semaglutide improved glucose control…

By Clara Rodríguez Fernández
18/08/2017 - 1 minute
News and Trends

German Biotech Unveils Positive Phase II Results for Alzheimer’s

Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead…

By Melanie De Almeida
12/06/2017 - 3 minutes
  • 1
  • 2
  • 3
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast